Cision PR Newswire

AICPA & CIMA’s first-ever China’s ENGAGE Asia Conference 2026 concludes the future of accounting and finance will be defined by trust, talent, and human...

SHANGHAI, Nov. 12, 2026 /PRNewswire/ -- ENGAGE Asia Conference 2026 brought together 600 business, finance and technology leaders from across Asia and around the world to explore the trends, opportunities and challenges shaping the future of organisations and the accounting and finance profession. Engage Asia...

IT Tech Packaging, Inc. Announces Reverse Stock Split

BAODING, China, Nov. 12, 2026 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP)...

HUMAIN Partners with VUZ to Advance a New Generation of Immersive AI Streaming and Learning by Launching HUMAIN Plus

This strategic partnership brings together HUMAIN and VUZ to launch a pioneering immersive video...

US ethanol readily available to fuel the world’s methanol-capable fleet, study finds

Study published by MEMA, a platform of the Global Centre for Green Fuels, finds...

High‑Trend International Group Announces Cancellation and Retirement of 630,000 Class A Ordinary Shares

NEW YORK, May 15, 2026 /PRNewswire/ -- High-Trend International Group (Nasdaq: HTCO, the "Company") today announced that it has completed the cancellation and retirement of...

POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results

GUANGZHOU, China, May 15, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in...

DeepQure Reports Encouraging Clinical Data from World’s First Extravascular RDN System at AUA 2026

WASHINGTON, May 15, 2026 /PRNewswire/ -- DeepQure, a clinical-stage medical device company, announced the completion of its featured presentation at the American Urological Association...

/DISREGARD RELEASE: New York Stock Exchange/

We are advised by New York Stock Exchange that journalists and other readers should disregard the news release, NYSE Content Update: Blackstone Digital Infrastructure...

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence NASHIK,...